Euglycaemic diabetic ketoacidosis in patients using sodium‐glucose co‐transporter 2 inhibitors

Sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) are an increasingly prescribed class of medication for type 2 diabetes mellitus. Euglycaemic diabetic ketoacidosis (euDKA) has been reported in association with SGLT2i use. Clinicians need to understand how to recognise and treat this complication....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Internal medicine journal 2017-06, Vol.47 (6), p.701-704
Hauptverfasser:	Isaacs, Michelle, Tonks, Katherine T., Greenfield, Jerry R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged, 80 and over Benzhydryl Compounds - adverse effects Diabetes Diabetes mellitus diabetes mellitus, type 2 Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - drug therapy diabetic ketoacidosis Diabetic Ketoacidosis - blood Diabetic Ketoacidosis - chemically induced Diabetic Ketoacidosis - diagnosis Female Glucose transporter Glucosides - adverse effects Humans hypoglycaemic agents Ketoacidosis Male Middle Aged Sodium Sodium-Glucose Transporter 2 Sodium-Glucose Transporter 2 Inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!